AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Hertraz 440mg Injection

Prescription Icon
Prescription Required

Marketer

Mylan Pharmaceuticals Pvt Ltd - A Viatris Company

Salt Composition

Trastuzumab (440mg)

Overview Hertraz 440mg Injection

Trastuzumab 440mg injection is indicated for treating breast and gastric cancers. Its mechanism involves targeting and destroying cancer cells by blocking HER2, a protein crucial for cancer growth. Administration is strictly by injection from a qualified healthcare provider. Dosage and frequency are determined by your physician, based on your condition and may be adjusted. Adhere precisely to your prescribed regimen; incorrect usage or overdose may lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinue only under medical guidance. Frequent side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can decrease blood cell counts (red and white), raising infection vulnerability. Regular blood tests monitoring blood cell levels, along with cardiac, hepatic, and uric acid levels, are necessary. Report any shortness of breath, cough, chills, or limb swelling to your doctor immediately. Drug interactions are possible; inform your healthcare team of all medications you're taking. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.

Uses of Hertraz 440mg Injection

Malignancies of the breast and stomach

Major Benefits of Hertraz 440mg Injection:

This medication will be administered by your healthcare provider; self-medication is strictly prohibited.

Common Side effects of Hertraz 440mg Injection:

  • Anemia (low number of red blood cells)
  • Chills
  • Common cold
  • Cough
  • Decreased blood cells (red cells, white cells, and platelets)
  • Diarrhea
  • Fatigue
  • Fever
  • Headache
  • Heart failure
  • Infection
  • Insomnia (difficulty in sleeping)
  • Mucosal inflammation
  • Nausea
  • Rash
  • Stomatitis (Inflammation of the mouth)
  • Taste change
  • Upper respiratory tract infection
  • Weight loss

How to use Hertraz 440mg Injection:

Administering this medication requires a healthcare professional; please do not attempt self-medication.

How Hertraz 440mg Injection works:

Trastuzumab 440mg Injection, a genetically engineered IgG1 monoclonal antibody, targets HER2 receptors—proteins that fuel excessive growth in breast and gastric cancers. By binding to HER2, it neutralizes these receptors, thereby halting cancer cell proliferation and disrupting multiple downstream signaling cascades crucial for tumor development.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Hertraz 440mg Injection and alcohol may lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Hertraz 440mg Injection during pregnancy poses a confirmed risk to the fetus and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks, justifying its use. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of the 440mg Hertraz injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Hertraz 440mg Injection's impact on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

The use of 440mg Hertraz injections in individuals with kidney impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary, but physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the administration of Hertraz 440mg Injection to individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Hertraz 440mg Injection :

Should you forget a Hertraz 440mg Injection, seek medical advice.

Facts to Know About Hertraz 440mg Injection

LabelValue
Chemical Type Monoclonal antibody
Developing Habits No.
Treatment Category Cancer Medications
Actions Monoclonal antibody HER2/neu (ErbB2) inhibitor

FAQs on Hertraz 440mg Injection

Hertraz 440mg Injection may cause side effects including sore throat, fever, chills, fatigue, pale skin, nosebleeds, unusual bruising or bleeding, stomach pain, seizures, hallucinations, muscle cramps and spasms, nausea, vomiting, loss of appetite, rapid heartbeat, discolored or decreased urine output, painful urination, and other signs of infection. Seek immediate medical attention if any of these occur.
Women of childbearing age must use effective contraception throughout Hertraz 440mg Injection therapy and for seven months afterward. Pregnancy planning can resume seven months post-treatment.
Herceptin 440mg Injection is prescribed for early-stage breast cancer patients for one year, or until disease recurrence, whichever comes first. Treatment should not exceed one year.
Herceptin 440mg Injection does not require fasting beforehand. Administration must be supervised by a healthcare professional experienced in administering cancer chemotherapy.
Hertraz 440mg Injection is available in two formulations: intravenous (IV) infusion and subcutaneous (under the skin) injection. Always verify the product label to administer the prescribed formulation. The IV formulation is for intravenous use only; it is not suitable for subcutaneous injection. Your doctor may change your treatment between IV and subcutaneous Hertraz 440mg Injection if clinically appropriate.
Hertraz 440mg Injection, a monoclonal antibody, targets the human epidermal growth factor receptor 2 (HER2) protein. Because it works by binding to HER2, found abundantly on some cancer cells, it's only effective in HER2-positive cancers. It's therefore contraindicated in patients with HER2-negative cancer.
Using Hertraz 440mg Injection with anthracycline-based cancer drugs (like doxorubicin) can harm your heart. Therefore, your doctor must assess your heart health before and throughout treatment.
Cardiac evaluations should begin at treatment initiation, continue every three months throughout treatment, and then every six months post-treatment for up to 24 months following the final Hertraz 440mg Injection dose. Patients with pre-existing cardiac conditions require evaluations every twelve weeks.
Hertraz 440mg Injection
50,693
MRP 58,820
13% off